caffeic acid has been researched along with Colitis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad, A; Khan, R; Kumar, A; Mishra, RK; Nadeem, A; Raza, SS; Sakla, R; Siddiqui, N; Vyawahare, A | 1 |
| Fan, C; Feng, C; Li, H; Liu, M; Lu, H; Lu, Q; Tang, W; Xiang, C; Yang, X | 1 |
| Cao, S; Feng, Y; Li, L; Wang, D; Wang, L; Wang, S; Wu, X; Yang, H; Zhang, Z | 1 |
| Henderson, A; Hendrich, S; Hostetter, J; Lee, K; Liu, Z; Wannemuehler, M; Ye, Z | 1 |
| Hendrich, S; Hong, CO; Hostetter, J; Lee, K; Wannemuehler, M; Ye, Z | 1 |
| Bautzová, T; Dvořáčková, K; Gajdziok, J; Lamprecht, A; Pellequer, Y; Rabišková, M; Spilková, J | 1 |
7 other study(ies) available for caffeic acid and Colitis
| Article | Year |
|---|---|
Caffeic Acid-Conjugated Budesonide-Loaded Nanomicelle Attenuates Inflammation in Experimental Colitis.
Topics: Animals; Budesonide; Colitis; Colitis, Ulcerative; Colon; Disease Models, Animal; Inflammation; Mice; Micelles | 2023 |
Blockade of TLRs-triggered macrophage activation by caffeic acid exerted protective effects on experimental ulcerative colitis.
Topics: Animals; Caffeic Acids; Cells, Cultured; Colitis; Dextran Sulfate; Disease Models, Animal; Humans; Inflammation Mediators; Inflammatory Bowel Diseases; Macrophage Activation; Macrophages; Male; Mice; Mice, Inbred C57BL; Toll-Like Receptors | 2021 |
Caffeic acid ameliorates colitis in association with increased Akkermansia population in the gut microbiota of mice.
Topics: Animals; Anti-Inflammatory Agents; Caffeic Acids; Colitis; Colon; Cytokines; Dextran Sulfate; Disease Models, Animal; Feces; Female; Gastrointestinal Microbiome; Inflammation Mediators; Macrophages; Mice, Inbred C57BL; Neutrophil Infiltration; Neutrophils; T-Lymphocytes; Time Factors; Verrucomicrobia | 2016 |
Increased CYP4B1 mRNA is associated with the inhibition of dextran sulfate sodium-induced colitis by caffeic acid in mice.
Topics: Alkynes; Animals; Antioxidants; Aryl Hydrocarbon Hydroxylases; Body Weight; Caffeic Acids; Colitis; Colon; Dextran Sulfate; Eating; Female; Gene Expression Regulation, Enzymologic; Glucosides; Humans; Inflammatory Bowel Diseases; Interleukin-17; Interleukin-4; Male; Mice; Nitric Oxide Synthase Type II; Organ Size; Peroxidase; RNA, Messenger; Rutin; Time Factors | 2009 |
Caffeic Acid inhibits colitis in a mouse model--is a drug-metabolizing gene crucial?
Topics: Animals; Antioxidants; Aryl Hydrocarbon Hydroxylases; Caffeic Acids; Colitis; Disease Models, Animal; Humans; Mice | 2009 |
Plasma caffeic acid is associated with statistical clustering of the anticolitic efficacy of caffeic acid in dextran sulfate sodium-treated mice.
Topics: Animals; Biological Availability; Caffeic Acids; Chromatography, High Pressure Liquid; Cluster Analysis; Colitis; Dextran Sulfate; Female; Mice; Polymerase Chain Reaction | 2011 |
Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation.
Topics: Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents; Buffers; Caffeic Acids; Chemistry, Pharmaceutical; Chitosan; Colitis; Colon; Disease Models, Animal; Drug Compounding; Drug Implants; Drug Stability; Gastrointestinal Agents; Glucuronic Acid; Hexuronic Acids; Hydrogen-Ion Concentration; Hypromellose Derivatives; Male; Methylcellulose; Rats; Rats, Wistar; Rutin; Solubility; Technology, Pharmaceutical; Time Factors; Trinitrobenzenesulfonic Acid; Zinc Acetate | 2012 |